Building global development strategies for cf therapeutics during a transitional cftr modulator era

Nicole Mayer-Hamblett, Silke van Koningsbruggen‐Rietschel, David P. Nichols, Donald R. VanDevanter, Jane C. Davies, T. Lee, Anthony G. Durmowicz, Félix Ratjen, Michael W. Konstan, Kelsie Pearson, Scott C. Bell, John Clancy, Jennifer L. Taylor‐Cousar, K. De Boeck, Scott H. Donaldson, D.G. Downey, Patrick A. Flume, Pavel Dřevı́nek, Christopher H. Goss, Isabelle Fajac, Amalia Magaret, Bradley S. Quon, Sabrina Singleton, Jill M. VanDalfsen, George Retsch‐Bogart